Ignite Creation Date:
2024-05-05 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00372710
Status:
TERMINATED
Last Update Posted:
2009-11-23
First Post:
2006-09-06
Brief Title:
SafetyEfficacy of Intravenous Zoledronic Acid When Added to Standard Therapies in Patients With Breast Cancer and Metastatic Bone Lesions
Sponsor:
Novartis
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CZOL446EDE03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None